VETERINARY TRANSDERMAL GEL COMPRISING ONDANSETRON, AND RELATED METHODS
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Sep 12, 2024
app pub date -
Jan 26, 2024
filing date -
Feb 28, 2023
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Disclosed is a pharmaceutical composition, comprising about 2% to about 10% w/w ondansetron or a pharmaceutically acceptable salt thereof, about 10% to about 50% w/w of one or more solvents, about 10% to about 50% w/w of one or more skin penetration enhancers, about 1% to about 5% w/w of one or more preservatives, and about 1% to about 20% w/w of one or more gelling agents. Also disclosed is a method for preventing or treating nausea and/or vomiting, comprising administering (e.g., transdermally) to a subject in need thereof a therapeutically effective amount of the pharmaceutical composition, thereby preventing or treating the nausea and/or vomiting.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully